BIRC5(survivin): a pejorative prognostic marker in stage...

Breast Cancer Research and Treatment 2016 / 10 Vol. 159; Iss. 3

BIRC5(survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy

Hamy, A. S., Bieche, I., Lehmann-Che, J., Scott, V., Bertheau, Ph., Guinebretière, J. M., Matthieu, M. C., Sigal-Zafrani, B., Tembo, O., Marty, M., Asselain, B., Spyratos, F., de Cremoux, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
159
Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-016-3961-2
Date:
October, 2016
File:
PDF, 459 KB
english, 2016
Conversion to is in progress
Conversion to is failed